Novartis Can't Rush Appeal In Elidel FCA Suit, Judge Says
By Linda Chiem (August 27, 2013, 1:14 PM EDT) -- A Pennsylvania federal judge on Friday denied Novartis Pharmaceuticals Corp.'s request to file an interlocutory appeal on part of her decision trimming down a whistleblower suit alleging the drugmaker defrauded government health care programs by promoting off-label uses of eczema treatment Elidel.
U.S. District Judge Gene E.K. Pratter denied Novartis' motion to certify a portion of her June 13 decision — in which she declined to dismiss outright the long-running suit from qui tam relator Donald Galmines but stripped the anti-kickback claims and certain state False Claims Act allegations — saying an immediate appeal to the Third Circuit wouldn't expedite the termination...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!